On August 21, LEADS BIOLABS-B fell 5.65% in regular trading, trading at HK$71.95/share, with turnover of HK$29.23 million.

Within the Biotechnology sector where LEADS BIOLABS-B belongs, the sector showed broad weakness. Among individual stocks, EVEREST MED down 8.85%, BEONE MEDICINES down 2.19%, AKESO down 2.13%, INNOVENT BIO down 0.4%, 3SBIO up 4.85%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)